FDA Drug Application (125104) for TYSABRI by BIOGEN IDEC

Back to FDA Applications sponsored by BIOGEN IDEC

Application Number125104
Product Number001
FormVIAL; SINGLE-USE
Dosage300MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTYSABRI
Active IngredientNATALIZUMAB



Back to FDA Applications sponsored by BIOGEN IDEC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.